[go: up one dir, main page]

AR071968A1 - Uso de un oligosacarido en el tratamiento de la inflamacion intestinal - Google Patents

Uso de un oligosacarido en el tratamiento de la inflamacion intestinal

Info

Publication number
AR071968A1
AR071968A1 ARP090101953A ARP090101953A AR071968A1 AR 071968 A1 AR071968 A1 AR 071968A1 AR P090101953 A ARP090101953 A AR P090101953A AR P090101953 A ARP090101953 A AR P090101953A AR 071968 A1 AR071968 A1 AR 071968A1
Authority
AR
Argentina
Prior art keywords
gal
treatment
glc
inflammation
oligosacarido
Prior art date
Application number
ARP090101953A
Other languages
English (en)
Inventor
Geogios Tzortzis
Jelena Vulevic
Original Assignee
Clasado Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Clasado Inc filed Critical Clasado Inc
Publication of AR071968A1 publication Critical patent/AR071968A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7016—Disaccharides, e.g. lactose, lactulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

La presente se refiere al uso de un oligosac rido, en particular una composicion de oligosac rido no digerible, en la prevencion o tratamiento de inflamacion, en particular inflamacion intestinal. Reivindicacion 4: La composicion de conformidad con la reivindicacion 3, caracterizada porque la mezcla de galactooligosac ridos comprende un disac rido Gal-Gal, un trisac rido Gal-Gal-Glc, un tetrasac rido Gal-Gal-Gal-Glc y un pentasac rido Gal-Gal-Gal-Gal-Glc. Reivindicacion 8: La composicion de conformidad con la reivindicacion 6, para uso al prevenir o reducir la inflamacion inducida por TNF-alfa (Factor de necrosis del tejido) en celulas de epitelio intestinal.
ARP090101953A 2008-05-30 2009-05-29 Uso de un oligosacarido en el tratamiento de la inflamacion intestinal AR071968A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0809921.0A GB0809921D0 (en) 2008-05-30 2008-05-30 Product and process therefor

Publications (1)

Publication Number Publication Date
AR071968A1 true AR071968A1 (es) 2010-07-28

Family

ID=39637923

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP090101953A AR071968A1 (es) 2008-05-30 2009-05-29 Uso de un oligosacarido en el tratamiento de la inflamacion intestinal

Country Status (9)

Country Link
US (1) US20110082102A1 (es)
EP (1) EP2288356A1 (es)
CN (1) CN102046181A (es)
AR (1) AR071968A1 (es)
AU (1) AU2009286558A1 (es)
CA (1) CA2724766A1 (es)
GB (1) GB0809921D0 (es)
TW (1) TW201000108A (es)
WO (1) WO2010023422A1 (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0525857D0 (en) * 2005-12-20 2006-02-01 Product and process
GB0606112D0 (en) 2006-03-28 2006-05-03 Product and process
GB0906983D0 (en) * 2009-04-23 2009-06-03 Clasado Inc Novel use
CA2763384C (en) 2009-05-27 2014-07-08 Clasado Inc Use of a composition of a mixture of galactooligosaccharides for preventing diarrhoea
DK2658549T3 (da) 2010-12-31 2020-06-29 Abbott Lab Fremgangsmåder til reduktion af incidensen af oxidativt stress under anvendelse af humane mælkeoligosaccharider, vitamin c og anti-inflammatoriske midler
MX376863B (es) 2010-12-31 2025-03-07 Abbott Lab Metodos para disminuir la incidencia de la enterocolitis necrotizante en bebes, infantes, o niños al usar los oligosacaridos de leche humana.
GB2492559B (en) * 2011-07-05 2018-07-25 Clasado Inc Composition and method for preventing or reducing the risk of developing a syndrome
PH12014500185A1 (en) 2011-07-22 2019-10-11 Abbott Lab Galactooligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract
SG2014013478A (en) 2011-08-29 2014-05-29 Abbott Lab Human milk oligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract
WO2013103826A1 (en) * 2012-01-06 2013-07-11 Skyview Enterprise Ltd. Anti-inflammatory compounds in combination with hydrogen for the treatment of inflammation
BR112014030570B1 (pt) 2012-06-08 2021-02-09 Finzelberg Gmbh & Co. Kg extratos de tomilho selvagem e uso destes
GB201305708D0 (en) * 2013-03-28 2013-05-15 Clasado Inc Novel use
WO2015007326A1 (en) * 2013-07-18 2015-01-22 Institut D'investigació Biomèdica De Bellvitge (Idibell) Agents comprising a terminal alpha-galactosyl moiety for use in prevention and/or treatment of inflammatory diseases
WO2015157163A1 (en) * 2014-04-07 2015-10-15 Rush University Medical Center Screening assay for choice of prebiotic to prevent/treat gastrointestinal and systemic diseases
PH12021552677A1 (en) * 2019-05-15 2022-07-04 Nutricia Nv Beta-1,3'-galactosyllactose for the treatment of gut barrier function diseases
LT3883393T (lt) * 2019-06-04 2022-12-27 N.V. Nutricia Mitybinė kompozicija, apimanti 2‘-fukozil-laktozę ir maistinį butiratą
PL3979827T3 (pl) 2019-06-04 2024-01-15 N.V. Nutricia Kompozycja żywieniowa zawierająca 2'fukozylolaktozę i 3'galaktozylolaktozę
EP4362708A1 (en) * 2021-07-01 2024-05-08 N.V. Nutricia Nutritonal compositions for gut barrier function

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4435389A (en) * 1980-07-07 1984-03-06 Kabushiki Kaisha Yakult Honsha Composition for promoting growth of bifidobacteria
JP2711095B2 (ja) * 1986-09-27 1998-02-10 ユニチカ株式会社 ビフイドバクテリウム菌の増殖促進剤の製造法
JP2518663B2 (ja) * 1987-12-24 1996-07-24 株式会社ヤクルト本社 ガラクトオリゴ糖含有加工乳の製造法
US5149640A (en) * 1988-12-22 1992-09-22 Ajinomoto Co., Inc. Method for producing galactose transfer products
WO2001090317A2 (en) * 2000-05-26 2001-11-29 Arla Foods Amba Beta-galactosidase isolated from a bifidobacterium
GB0229015D0 (en) * 2002-12-12 2003-01-15 Novartis Nutrition Ag New Compound
MXPA05010349A (es) * 2003-06-30 2006-03-08 Clasado Inc Composicion novedosa de galactooligosacaridos y preparacion de la misma.

Also Published As

Publication number Publication date
CA2724766A1 (en) 2010-03-04
WO2010023422A8 (en) 2010-12-02
CN102046181A (zh) 2011-05-04
WO2010023422A1 (en) 2010-03-04
TW201000108A (en) 2010-01-01
US20110082102A1 (en) 2011-04-07
EP2288356A1 (en) 2011-03-02
GB0809921D0 (en) 2008-07-09
AU2009286558A1 (en) 2010-03-04

Similar Documents

Publication Publication Date Title
AR071968A1 (es) Uso de un oligosacarido en el tratamiento de la inflamacion intestinal
MX2020007226A (es) Composiciones de corticosteroides administradas oralmente.
ECSP11011459A (es) Composiciones sublinguales de dexmedetomidina y métodos de uso de ellas
EP4327867A3 (en) Pharmaceutical composition comprising glucopyranosyl diphenylmethane derivatives, pharmaceutical dosage form thereof, process for their preparation and uses thereof for improved glycemic control in a patient
EA021554B9 (ru) Органические соединения и их применение для лечения hcv инфекции
NI201100043A (es) Derivados de dioxa - biciclo [ 3. 2. 1 ] octano - 2, 3, 4 - triol.
ES2356883A1 (es) Composicion para el tratamiento del dolor y/o la inflamacion.
CL2008001373A1 (es) Compuestos derivados de fenilamino-benceno sustituidos; metodo de preparacion; composicion farmaceutica; kit farmceuticos; y uso de dichos compuestos en el tratamiento del cancer.
PL1986669T3 (pl) Zastosowanie Bifidobacterium longum do zapobiegania i leczenia zapalenia
PH12013500472A1 (en) Piperidinyl-substituted lactams as gpr119 modulators
IN2012DN02645A (es)
BR112014015940A2 (pt) composição de novo fármaco de carboidrato para tratamento de doenças humanas
MX353712B (es) Formulaciones de sulfoxido de dimetilo (dmso) y metilsulfonilmetano (msm) para tratar osteoartritis.
AR077125A1 (es) Combinaciones farmaceuticas utiles para tratar el vhc
CL2008003546A1 (es) Compuestos derivados de piridina; procedimiento de preparacion; composicion farmaceutica de dichos compuestos; y uso en el tratamiento y/o profilaxis de la diabetes mellitus tipo i y/o tipo ii.
NZ592049A (en) Compositions and methods for the treatment of bowel diseases with granulated mesalamine
BR112012015386B8 (pt) composição oftálmica tópica
WO2007133796A3 (en) Methods and compositions for treatment of sleep apnea comprising administration of an endothelin antagonist
WO2010151004A3 (ko) 하이드록시클로로퀸을 함유하는 치핵 치료를 위한 국소투여용 주사제 조성물
WO2010086617A3 (en) Phosphoantigens for the treatment of burkholderia infections
WO2011151786A3 (en) Injectable formulation of a reverse transcriptase inhibitor for the treatment cancer
AR072066A1 (es) Uso de composicion que comprende oligosacaridos no digeribles
CL2010001589A1 (es) Compuestos derivados de 3-ciano-pirrolidin-fenil-oxazolidinonas; procedimiento de preparacion; composicion farmaceutica; y uso en el tratamiento de infecciones bacterianas.
BR112012006027A2 (pt) composições e métodos para tratar distúrbios de motilidade gastrointestinal.
尹庆水 Application of transoral atlantoaxial reduction plate Ⅲ in treatment of complicated atlantoaxial dislocation

Legal Events

Date Code Title Description
FB Suspension of granting procedure